Vox sanguinis · 2026
Association between NT-proBNP and false-positive Coombs test in patients with heart failure and elevated NT-proBNP.
СтатьяНаблюдательное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lamilla Álvarez Ana, Cámara Rodenas María Asunción, Russo Botero Sofía, Aracil Boigues Pau, Játiva Sáez Cristina, Vidal Rico Elena, Santos Cañamares Elena, Rangel Algaba Alma, Ortiz-Zuluaga Sebastian, Marco Buades Josefa Esperanza, Fácila Rubio Lorenzo, Pérez-Silvestre José, López-Pavía María de la Encarnación
Аннотация
BACKGROUND AND OBJECTIVES: The human antiglobulin test or Coombs' test is a key tool in the diagnosis and classification of haemolytic anaemia and could present as falsely positive. A retrospective study has described that B-type natriuretic peptide (NT-proBNP), a biomarker used for heart failure (HF), could be an additional cause of false positives in the Coombs test.
MATERIALS AND METHODS: A prospective, observational, single-centre study was conducted in adult patients diagnosed with HF between October 2024 and March 2025 at a tertiary hospital. The Coombs' test was considered as false positive in cases in which the specificity of the test included immunoglobulin G (IgG), the subsequent elution yielded a negative result, and blood haemolysis parameters were within normal ranges.
RESULTS: Thirty-six patients were included, of whom nine (25%) had a false-positive Coombs test. These patients had significantly higher levels of NT-proBNP (10,825 pg/mL [2587-35,000] vs. 3314 pg/mL [278-11,856], p = 0.0076) and lower glomerular filtration rate (35.3 mL/min/1.73 m2 [23.6-46.3] vs. 63.3 mL/min/1.73 m2 [21.9-90.0], p = 0.0055) compared to patients with a negative Coombs test. No statistically significant associations were found with drugs used concomitantly for HF.
CONCLUSION: The results suggest that elevated NT-proBNP could also be a cause of false positives in the Coombs test.
MATERIALS AND METHODS: A prospective, observational, single-centre study was conducted in adult patients diagnosed with HF between October 2024 and March 2025 at a tertiary hospital. The Coombs' test was considered as false positive in cases in which the specificity of the test included immunoglobulin G (IgG), the subsequent elution yielded a negative result, and blood haemolysis parameters were within normal ranges.
RESULTS: Thirty-six patients were included, of whom nine (25%) had a false-positive Coombs test. These patients had significantly higher levels of NT-proBNP (10,825 pg/mL [2587-35,000] vs. 3314 pg/mL [278-11,856], p = 0.0076) and lower glomerular filtration rate (35.3 mL/min/1.73 m2 [23.6-46.3] vs. 63.3 mL/min/1.73 m2 [21.9-90.0], p = 0.0055) compared to patients with a negative Coombs test. No statistically significant associations were found with drugs used concomitantly for HF.
CONCLUSION: The results suggest that elevated NT-proBNP could also be a cause of false positives in the Coombs test.